Journal of Yeungnam Medical Science

Case Report

Colchicine for steroid-resistant recurrent pericarditis in a child: Ju Hee Shin, Dong Hyun Lee, Hee Joung Choi; Yeungnam Univ J Med. 2018;35(2):222-226. Published online December 31, 2018; DOI: https://doi.org/10.12701/yujm.2018.35.2.222

6,069 View
85 Download
4 Crossref

Recurrent pericarditis is rare in children and is considered idiopathic in most cases. Its course is chronic, and preventing recurrences is important for the patient’s quality of life. Although a treatment strategy in pediatric recurrent pericarditis has not yet been established, non-steroidal anti-inflammatory drugs (NSAIDs) are the most common treatment for management of this condition, followed by corticosteroids, colchicine, immunosuppressive agents, immunoglobulins, and interleukin-1β receptor antagonists (e.g. anakinra). Herein, we report a case of recurrent pericarditis with pericardial effusion in a 5-year-old child who presented with fever and epigastric pain. He responded poorly to NSAIDs and corticosteroid therapy, but was successfully treated with colchicine.

Citations

Citations to this article as recorded by

Anakinra in idiopathic recurrent pericarditis: a comprehensive case series and literature review
Zeynep Toker Dincer, Sejla Karup, Erkin Yilmaz, Osman Corbali, Feyza Nur Azman, Melike Melikoglu, Serdal Ugurlu
Zeitschrift für Rheumatologie.2024; 83(7): 587. CrossRef
Efficacy and Safety of Colchicine in Pediatric Pericarditis: A Systematic Review and Future Directions
Mohammed Alsabri, Sarah Makram Elsayed, Ahmed Bostamy Elsnhory, Khaled Abouelmagd, Mohammed Ayyad, Basel F. Alqeeq, Abdelmonem Siddiq, Yousef Soliman, Muhammad Azan Shahid
Pediatric Cardiology.2024;[Epub] CrossRef
Pediatric Pericarditis: Update
Rida Shahid, Justin Jin, Kyle Hope, Hari Tunuguntla, Shahnawaz Amdani
Current Cardiology Reports.2023;[Epub] CrossRef
Effects of Systemic Steroid Administration on Recurrence of Pericardial Effusion in Pediatric Patients After Hematopoietic Stem Cell Transplantation
Kieran Leong, Martha E. Heal, John L. Bass, Varun Aggarwal, Shanti Narasimhan, Ashish Gupta, Gurumurthy Hiremath
Journal of Pediatric Hematology/Oncology.2020; 42(4): 256. CrossRef

Original Article

Investigation of right ventricle function in patients with tetralogy of Fallot after total correction using cardiac magnetic resonance imaging: Woo Sung Jang, Hee Joung Choi, Jong Min Lee, Jae Bum Kim, Jae Hyun Kim, Jae Seok Jang; Yeungnam Univ J Med. 2017;34(2):238-241. Published online December 31, 2017; DOI: https://doi.org/10.12701/yujm.2017.34.2.238

2,552 View
6 Download

Abstract PDF: BACKGROUND
We investigated the difference in right ventricle (RV) volume and ejection fraction (EF) according to the pulmonary valve (PV) annular extension technique during Tetralogy of Fallot (TOF) total correction. METHODS: We divided patients who underwent the procedure from 1993 to 2003 into two groups according to PV extension technique (group I: PV annular extension, group II: no PV annular extension) during TOF total correction. We then analyzed the three segmental (RV inlet, trabecular and outlet) and whole RV volume and EF by cardiac magnetic resonance imaging (MRI). RESULTS: Fourteen patients were included in this study (group I: 10 patients, group II: four patients; male: nine patients, female: five patients). Cardiac MRI was conducted after a 16.1 years TOF total correction follow-up period. There was no statistical difference in RV segmental volume index or EF between groups (all p>0.05). Moreover, the total RV volume index and EF did not differ significantly between groups (all p>0.05). CONCLUSION: The RV volume and EF of the PV annular extension group did not differ from that of the PV annular extension group. Thus, PV annular preservation technique did not show the surgical advantage compared to PV annular extension technique in this study.

First
Prev
Page of 1
Next
Last

Search